IMRIS Inc. (IMRSQ) ist ein börsennotiertes Unternehmen im Gesundheitswesen Sektor, tätig in der Medical - Specialties Branche. Der aktuelle CEO ist Shalabh Chandra.
IMRSQ hat IPO-Datum 2023-01-20, 121 Vollzeitbeschäftigte, gelistet an der Other OTC, eine Marktkapitalisierung von $626.00.
IMRIS Inc. designs, manufactures, and sells image-guided therapy solutions worldwide. The company offers VISIUS Surgical Theatres, a surgical environment that provides intraoperative vision to clinicians to assist in decision-making and enhance precision in treatment. Its VISIUS Surgical Theatre incorporates magnetic resonance imaging, computed tomography, and fluoroscopy into multi-purpose surgical suites to provide intraoperative imaging for specific medical applications by bringing advanced imaging into the operating room (OR). The company sells the VISIUS Surgical Theatres to hospitals that deliver clinical services to patients in the neurosurgical, spinal, cerebrovascular, and cardiovascular markets. It also provides service and extended maintenance contracts, and accessories and disposables. The company was founded in 2005 and is based in Winnipeg, Canada.
